Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03150563
Other study ID # 1.883.129
Secondary ID
Status Recruiting
Phase N/A
First received May 6, 2017
Last updated May 9, 2017
Start date May 9, 2017
Est. completion date November 30, 2017

Study information

Verified date May 2017
Source Universidade Federal do Rio Grande do Norte
Contact Ronan R Varela de Melo, Master
Phone +5584991366307
Email ronanriq@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intensity is a "qualitative" variable of a muscle stretching protocol, which is very little studied due to its inherent characteristic of the individual being stretched. However, it was pointed out as an important factor for ADM gain. To verify the effects of different intensities of static passive stretching on flexibility, neuromuscular and functional performance in soccer athletes.


Description:

It is a randomized, controlled, clinical trial, composed of male subjects, soccer players, randomly divided into 4 groups: Control Group (CG), Experimental Group 1 (GE1), Experimental Group 2 (GE2) And Experimental Group 3 (GE3). Initially, the measurements of flexibility (passive and active), neuromuscular (muscular passive torque, electromyographic activity), and functional (vertical jump and shuttle run test) of non-dominant lower limbs, performed before and immediately after the 1st And 48 hours after the last session. The GC will only be submitted for initial evaluation and final re-evaluation. The experimental groups will undergo a protocol of static passive stretching containing 10 sessions, divided into 3 weekly sessions, with 3 maneuvers of 30 s, but with different intensities (Tolerable Maximum Pain, Maximum No Pain Discomfort, and Stretching Sensation Without Discomfort) Established from a PERFLEX-modified visual scale. Groups with higher static passive stretching intensities (Maximum Tolerable Pain and Maximum Painless Discomfort) are expected to have greater gains in flexibility, with no change in muscle passive torque, electromyographic activity and functional performance, while the intensity of Feeling of Stretching without Discomfort (in a comfort zone) provides a greater decrease of the muscular passive torque, without significant change of the flexibility, in individual athletes of soccer. This work may contribute to the clinical practice of health professionals, since it seeks to improve the elaboration of the clinical prescription of protocols of static passive stretching (whether performed by the individual or not), establishing optimal levels of intensity for a given muscle group.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date November 30, 2017
Est. primary completion date September 30, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- (1) being male; (2) age range between 18 and 35 years of age; (3) Body Mass Index (BMI) between 19 and 27; (4) be a soccer player with 4 to 5x weekly training; (5) not participating in lower limb stretching programs; (6) no history of injury, trauma, previous surgeries and lower limb disease in the last 6 months; (7) absence of musculoskeletal, cardiorespiratory and neurological disorders that prevent the accomplishment of evaluation and treatment protocols; (8) not under the action of drugs that cause muscle relaxation or that may inhibit tonic muscle action (9) present a limitation of WMD (muscular shortening degree) with ischiatibial extensibility of less than 165 degrees of active extension of the knee with the hip Flexed at 90 °.

Exclusion Criteria:

- (1) initiate stretching practice involving LLLs in daily activities outside the collection site during the study period; (2) not performing any of the evaluation and / or intervention procedures; (3) discontinuance in participating in the research.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Passive static stretch
Each experimental group will be submitted to 10 (ten) sessions, with three (3) weekly sessions of static passive stretching, with a 48 h interval between them. Each session will be performed 3 (three) maneuvers containing a duration of 30 seconds, this being the same rest time, performed in all experimental groups.

Locations

Country Name City State
Brazil Federal University of Rio Grande do Norte Natal RN

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal do Rio Grande do Norte

Country where clinical trial is conducted

Brazil, 

References & Publications (2)

Apostolopoulos N, Metsios GS, Flouris AD, Koutedakis Y, Wyon MA. The relevance of stretch intensity and position-a systematic review. Front Psychol. 2015 Aug 18;6:1128. doi: 10.3389/fpsyg.2015.01128. eCollection 2015. Review. — View Citation

Behm DG, Bradbury EE, Haynes AT, Hodder JN, Leonard AM, Paddock NR. Flexibility is not Related to Stretch-Induced Deficits in Force or Power. J Sports Sci Med. 2006 Mar 1;5(1):33-42. eCollection 2006. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Range of motion (ROM) The measurement will be performed in two positions: with hip flexed at 90 ° and with extended leg elevation, using goniometry for measurement. 48 h after intervention
Secondary Pleasure after stretching program Each volunteer will be asked shortly after each session what was the pleasure felt in achieving the sensation of stretching, which is indicated by the feeling scale. 1 minute after intervention
Secondary Pain after stretching session Measurement from the visual analogue scale of 100 mm. 1 minute after intervention
Secondary Functional performance Evaluation of functional performance with measures of vertical jump and shuttle run 48 h after intervention
Secondary Electromyographic responses of the hamstring Electromyographic responses of the hamstring muscles in performing knee extension and hip flexion 48 h after intervention
Secondary Passive torque Isokinetic performance evaluation 48 h after intervention
See also
  Status Clinical Trial Phase
Completed NCT05711953 - Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief N/A
Completed NCT00001550 - Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS) Phase 1